# Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease

> **NCT03082755** · PHASE4 · RECRUITING · sponsor: **University of Texas at Austin** · enrollment: 156 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Gabapentin Enacarbil
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03082755
- **Lead sponsor:** University of Texas at Austin
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-07-01
- **Primary completion:** 2022-08-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2022-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03082755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03082755, "Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03082755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*